Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Chemomab Therapeutics Ltd ADR
(NQ:
CMMB
)
1.400
+0.180 (+14.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Chemomab Therapeutics Ltd ADR
< Previous
1
2
3
4
Next >
CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q2 2024
August 21, 2024
Chemomab Therapeutics just reported results for the second quarter of 2024.
Via
InvestorPlace
Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise
July 25, 2024
Chemomab Therapeutics reports successful Phase 2 SPRING trial results for CM-101 in primary sclerosing cholangitis, showing safety and efficacy. Key findings include significant improvements in liver...
Via
Benzinga
CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q1 2024
May 09, 2024
Chemomab Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
May 06, 2024
Via
Benzinga
CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q4 2023
March 07, 2024
Chemomab Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 22, 2024
Via
Benzinga
A Preview Of Chemomab Therapeutics's Earnings
March 30, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via
Benzinga
What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?
February 20, 2024
Chemomab Therapeutics' CM-101 granted new patents in Brazil and Israel, currently in Phase 2 SPRING trial for primary sclerosing cholangitis. Topline data readout expected by mid-2024.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
January 18, 2024
Shares of M.D.C. Holdings, Inc. (NYSE: MDC) rose sharply in today’s pre-market trading. Sekisui House, Ltd. and M.D.C. Holdings announced an agreement pursuant to which a wholly-owned subsidiary of...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 18, 2024
Pre-market stock movers are a hot topic this morning as we check out all of the winners and losers worth keeping tabs on for Thursday!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 29, 2023
Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning!
Via
InvestorPlace
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 16, 2023
Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.
Via
Benzinga
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
November 16, 2023
Shares of Palo Alto Networks, Inc. (NASDAQ: PANW) fell in pre-market trading after reporting first-quarter results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 16, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!
Via
InvestorPlace
Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
November 15, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. The Dow traded up 0.46% to 34,989.30 while the NASDAQ rose 0.16% to 14,116.28. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 15, 2023
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
Via
Benzinga
US Stocks Gain; Producer Prices Fall In October
November 15, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 90 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.27% to 34,922.07 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why is Liver Disease Focused Chemomab Stock Trading Higher Today?
November 15, 2023
Chemomab Therapeutics Ltd (NASDAQ: CMMB) shares are trading higher after the FDA granted CM-101 Fast Track designation for adult patients of primary sclerosing cholangitis (PSC),
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 22, 2023
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...
Via
Benzinga
What's Going On With Chemomab Therapeutics Stock Today
June 21, 2023
Chemomab Therapeutics Ltd (NASDAQ: CMMB) reported topline results from secondary Phase 2a liver fibrosis trial analyses assessing CM-101 in patients with
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
June 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 22, 2023
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Via
Benzinga
Why Chemomab Therapeutics Shares Are Trading Higher Today
February 21, 2023
Chemomab Therapeutics Ltd (NASDAQ: CMMB) shares are trading higher on Tuesday after the company announced FDA clearance of its Investigational New Drug Application to evaluate CM-101 in a Phase 2 trial...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 21, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.